Factors associated with poorer quality of life in people living with HIV in southwestern France in 2018-2020 (ANRS CO3 AQUIVIH-NA cohort: QuAliV study).


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
02 10 2023
Historique:
received: 03 04 2023
accepted: 23 09 2023
medline: 4 10 2023
pubmed: 3 10 2023
entrez: 2 10 2023
Statut: epublish

Résumé

We evaluated people living with Human Immunodeficiency Virus' (PLWH) quality of life (QoL) and assessed whether their demographic, disease-related, socioeconomic, or behavioral characteristics were associated with poorer QoL. ANRS CO3 AQUIVIH-NA cohort participants (Nouvelle Aquitaine, France) were recruited to a cross-sectional study (2018-2020) and their QoL assessed (WHOQOL-BREF). We calculated median (Q1, Q3) QoL domain scores and assessed factors associated with poorer median QoL using bivariable and multivariable quartile regression. Of the 965 PLWH included, 98.4% were on antiretroviral therapy, 94.7% were virally-suppressed, 63.5% reported good/very good QoL. Median scores (0-100) were highest for physical (69;Q1, Q3: 56, 81) and environmental (69; 56, 75) QoL and lowest for social (56; 44, 69) and psychological (56; 44, 69) QoL. PLWH with ≥ 3 comorbidities, HIV-related stigma, or income of < 1500€/month had poorer median adjusted physical, psychological, social, and environmental QoL scores compared to reference groups. While more than half of PLWH reported good/very good QoL, we have not achieved good QoL in 90% of PLWH. Multi-morbidity, HIV-related stigma, and social determinants were consistently and independently associated with poorer QoL. Addressing structural factors in addition to those indirectly related to HIV is required to attain good QoL in all PLWH.

Identifiants

pubmed: 37783722
doi: 10.1038/s41598-023-43434-x
pii: 10.1038/s41598-023-43434-x
pmc: PMC10545822
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16535

Informations de copyright

© 2023. Springer Nature Limited.

Références

HIV Med. 2011 Jan;12(1):22-30
pubmed: 20497251
Health Qual Life Outcomes. 2013 Apr 08;11:56
pubmed: 23566318
AIDS Patient Care STDS. 2013 Jan;27(1):5-16
pubmed: 23305257
Lancet Infect Dis. 2015 Jul;15(7):810-8
pubmed: 26070969
Arch Public Health. 2014 Nov 17;72(1):40
pubmed: 25671112
BMJ Open. 2016 Jul 13;6(7):e011453
pubmed: 27412106
Qual Life Res. 2007 May;16(4):577-91
pubmed: 17268929
AIDS Patient Care STDS. 2004 Oct;18(10):594-603
pubmed: 15630787
Drug Alcohol Depend. 2007 Jan 12;86(2-3):175-82
pubmed: 16930864
Soc Sci Med. 1995 Nov;41(10):1403-9
pubmed: 8560308
Sci Rep. 2022 Apr 16;12(1):6364
pubmed: 35430622
JMIR Res Protoc. 2018 Jun 07;7(6):e147
pubmed: 29880467
JAMA. 1993 Feb 10;269(6):729-30
pubmed: 8093740
Lancet Reg Health Eur. 2021 Jul 19;8:100177
pubmed: 34557859
JAMA. 1995 Jan 4;273(1):59-65
pubmed: 7996652
Lancet HIV. 2020 Feb;7(2):e129-e140
pubmed: 31776098
Curr Opin HIV AIDS. 2023 Mar 1;18(2):59-67
pubmed: 36655695
BMC Med. 2016 Jun 22;14(1):94
pubmed: 27334606
BMC Infect Dis. 2021 Sep 13;21(Suppl 2):898
pubmed: 34517820
J Int AIDS Soc. 2014 Jun 17;17:19034
pubmed: 24942364
J Acquir Immune Defic Syndr. 2006 Aug 1;42(4):470-7
pubmed: 16810114
Lancet HIV. 2014 Oct;1(1):e32-40
pubmed: 26423814
J Gen Intern Med. 2005 Dec;20(12):1142-5
pubmed: 16423106
Health Qual Life Outcomes. 2020 Jul 10;18(1):220
pubmed: 32650781
AIDS Care. 2003 Aug;15(4):581-90
pubmed: 14509872
Qual Life Res. 2000;9(9):977-85
pubmed: 11332226
J Nurs Scholarsh. 2005;37(4):336-42
pubmed: 16396406
AIDS. 2007 Jan;21 Suppl 1:S19-27
pubmed: 17159583

Auteurs

Diana Barger (D)

Univ. Bordeaux, INSERM, BPH, U1219, 33000, Bordeaux, France. diana.barger@u-bordeaux.fr.

Mojgan Hessamfar (M)

Univ. Bordeaux, INSERM, BPH, U1219, 33000, Bordeaux, France.
CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Hôpital Saint-André, 33000, Bordeaux, France.
CHU de Bordeaux, COREVIH Nouvelle Aquitaine, INSERM, U1219, 33000, Bordeaux, France.

Didier Neau (D)

CHU de Bordeaux, Service des Maladies Infectieuses et Tropicales, INSERM, U1219, 33000, Bordeaux, France.

Sophie Farbos (S)

CH de la Côte Basque, Service de Maladies Infectieuses, 64000, Bayonne, France.

Olivier Leleux (O)

Univ. Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, 33000, Bordeaux, France.

Charles Cazanave (C)

CHU de Bordeaux, Service des Maladies Infectieuses et Tropicales, INSERM, U1219, 33000, Bordeaux, France.

Nicolas Rouanes (N)

CH de Périgueux, Service de Médecine Polyvalente, 24019, Périgueux, France.

Pierre Duffau (P)

CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Hôpital Saint-André, 33000, Bordeaux, France.
Univ. Bordeaux, Department of Immunology, CNRS, ImmunoConcEpT, UMR 5164, 33000, Bordeaux, France.

Estibaliz Lazaro (E)

CHU de Bordeaux, Service de Médecine Interne, 33604, Pessac, France.

Patrick Rispal (P)

CH de Agen-Nerac, Service de Médecine Interne, 47923, Agen, France.

François Dabis (F)

Univ. Bordeaux, INSERM, BPH, U1219, 33000, Bordeaux, France.
CHU de Bordeaux, COREVIH Nouvelle Aquitaine, INSERM, U1219, 33000, Bordeaux, France.

Linda Wittkop (L)

Univ. Bordeaux, INSERM, BPH, U1219, 33000, Bordeaux, France.
Univ. Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, 33000, Bordeaux, France.
INRIA, SISTEM Team, 33400, Talence, France.
CHU de Bordeaux, Service d'information médicale, INSERM, Institut Bergonié, CIC-EC 1401, 33000, Bordeaux, France.

Fabrice Bonnet (F)

Univ. Bordeaux, INSERM, BPH, U1219, 33000, Bordeaux, France.
CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Hôpital Saint-André, 33000, Bordeaux, France.
Univ. Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, 33000, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH